HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)

Journal:

Gut

Published:

2025-11-05

DOI:

10.1136/gutjnl-2025-336251

Affiliations:

20

Authors:

19

Go to article

Institutions	Authors	Share
Erasmus University Medical Center (Erasmus MC), Netherlands	4.833333	0.25
Ruijin Hospital, SJTU, China	2.000000	0.11
Toronto General Hospital (TGH), U of T, Canada	1.833333	0.10
Shanghai Public Health Clinical Center, Fudan University, China	1.500000	0.08
Viral Hepatitis Care Network (VIRCAN), Canada	1.000000	0.05
Pierre Louis Institute of Epidemiology and Public Health (iPLESP), France	1.000000	0.05
Unité Mixte de Recherche Physiopathologie et Traitement des Maladies Hépathiques (PaThLiv), France	1.000000	0.05
Hospital del Mar, Spain	0.833333	0.04
Hospital del Mar Medical Research Institute (IMIM), Spain	0.833333	0.04
National University Health System (NUHS), Singapore	0.500000	0.03
National University of Singapore (NUS), Singapore	0.500000	0.03
Hôpital Saint Joseph - Marseille, France	0.500000	0.03
Economic and Social Sciences, Health Systems and Medical Informatics (SESSTIM), France	0.500000	0.03
Huashan Hospital, Fudan University, China	0.500000	0.03
Hôpital Avicenne, France	0.333333	0.02
Université Sorbonne Paris-Nord, France	0.333333	0.02
Cordelier Research Center (CRC), France	0.333333	0.02
Pompeu Fabra University (UPF), Spain	0.333333	0.02
University of Toronto (U of T), Canada	0.333333	0.02

Interested in Medical Microbiology?